Windward Bio secures $165M in funding led by OrbiMed to advance its lead candidate WIN378 into Phase 3 and WIN027 into studies by Q4 2026.
Amount Raised
$165 Million
Round Type
Funding Round
BaselBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaInvestors
Description
Windward Bio, a Basel-based biotechnology company, raised $165M in funding. The round was led by OrbiMed with multiple investors participating. The funds will help advance lead candidate WIN378 into Phase 3 and WIN027 into studies by Q4 2026. Windward Bio focuses on treating serious immunological conditions with its innovative therapies.
Quick answer
Windward Bio raised $165 Million in a Funding Round round, dated May 5, 2026. Investors: Pivotal bioVenture Partners, Harbour BioMed, Orbimed, Novo Holdings, Blue Owl Healthcare Opportunities, SR One, Omega Funds and RTW Investments. Windward Bio is based in Basel, Basel City, Switzerland.
- How much did Windward Bio raise?
- Windward Bio raised $165 Million in a Funding Round round on May 5, 2026.
- Who invested in Windward Bio?
- Pivotal bioVenture Partners, Harbour BioMed, Orbimed, Novo Holdings, Blue Owl Healthcare Opportunities, SR One, Omega Funds and RTW Investments are named as investors in this round.
- What does Windward Bio do?
- Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases with an initial focus on severe respiratory conditions.
- Where is Windward Bio based and how big is it?
- Windward Bio is based in Basel, Basel City, Switzerland. Fundz records about 40 employees.
- Who are the decision-makers at Windward Bio?
- Fundz holds 2 contacts at Windward Bio, including the Chief Medical Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Windward Bio that raised within 45 days of this round, from Fundz verified event records.
- Citius Oncology raised $37M on May 6, 2026.
- Lighthouse Pharmaceuticals raised $15M (Series A) on April 22, 2026.
- Edesa Biotech raised $3.5M on June 16, 2026.
- Tempest Therapeutics raised $4.1M on May 29, 2026.
- HCW Biologics raised $4M on May 21, 2026.
- AIM ImmunoTech raised $2.4M (Post-IPO Equity) on May 20, 2026.
Who to call at Windward Bio, and when
A new round usually means Windward Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Windward Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Windward Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Windward Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Windward Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Windward Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.